Clinical Trial Update: Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study [NA]

View source ↗

Summary

A single-center feasibility study evaluating whether neuromodulation can help treat chemotherapy-induced peripheral neuropathy, using nerve markers and sensory/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Neuropathy;Peripheral | NA | Status: ACTIVE_NOT_RECRUITING